CD26/dipeptidylpeptidase IV-chemokine interactions: double-edged regulation of inflammation and tumor biology (Q38690194)

5 September 2017

2 references

8 February 2021

5 April 2021

CD26/dipeptidylpeptidase IV-chemokine interactions: double-edged regulation of inflammation and tumor biology (English)

1 reference

5 September 2017

0 references

1 reference

8 February 2021

1 reference

5 April 2021

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26744452 AND SRC:MED&resulttype=core&format=json

10 June 2020

Paul Proost

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26744452 AND SRC:MED&resulttype=core&format=json

10 June 2020

Sofie Struyf

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26744452 AND SRC:MED&resulttype=core&format=json

10 June 2020

author name string

Anneleen Mortier

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26744452 AND SRC:MED&resulttype=core&format=json

10 June 2020

Mieke Gouwy

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26744452 AND SRC:MED&resulttype=core&format=json

10 June 2020

publication date

7 January 2016

1 reference

26744452

Journal of Leukocyte Biology

5 September 2017

1 June 2016

2 references

8 February 2021

5 April 2021

3 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26744452 AND SRC:MED&resulttype=core&format=json

10 June 2020

8 February 2021

5 April 2021

99

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26744452 AND SRC:MED&resulttype=core&format=json

10 June 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26744452 AND SRC:MED&resulttype=core&format=json

10 June 2020

page(s)

955-969

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26744452 AND SRC:MED&resulttype=core&format=json

Understanding dendritic cell and T-lymphocyte traffic through the analysis of chemokine receptor expression

10 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Regulation of the immune response by the interaction of chemokines and proteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

International Union of Pharmacology. XXX. Update on chemokine receptor nomenclature

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Tuning inflammation and immunity by chemokine sequestration: decoys and more

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Interaction of chemokines and glycosaminoglycans: a new twist in the regulation of chemokine function with opportunities for therapeutic intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

The Positively Charged COOH-terminal Glycosaminoglycan-binding CXCL9(74-103) Peptide Inhibits CXCL8-induced Neutrophil Extravasation and Monosodium Urate Crystal-induced Gout in Mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Structure-based design of decoy chemokines as a way to explore the pharmacological potential of glycosaminoglycans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Overview of the mechanisms regulating chemokine activity and availability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

The chemokine receptor switch paradigm and dendritic cell migration: its significance in tumor tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Possible mechanisms involved in chemokine synergy fine tuning the inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Chemokines and other GPCR ligands synergize in receptor-mediated migration of monocyte-derived immature and mature dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Regulation of chemokine activity by posttranslational modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Effect of posttranslational processing on the in vitro and in vivo activity of chemokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Chemokine-protease interactions in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Biological activity of CXCL8 forms generated by alternative cleavage of the signal peptide or by aminopeptidase-mediated truncation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Generation of the neutrophil-activating peptide NAP-2 from platelet basic protein or connective tissue-activating peptide III through monocyte proteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Effects of the neutrophil-activating peptide NAP-2, platelet basic protein, connective tissue-activating peptide III and platelet factor 4 on human neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Structure and bioactivity of recombinant human CTAP-III and NAP-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Regulation of the Receptor Specificity and Function of the Chemokine RANTES (Regulated on Activation, Normal T Cell Expressed and Secreted) by Dipeptidyl Peptidase IV (CD26)-mediated Cleavage

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Amino-terminal truncation of chemokines by CD26/dipeptidyl-peptidase IV. Conversion of RANTES into a potent inhibitor of monocyte chemotaxis and HIV-1-infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

CD26-processed RANTES(3-68), but not intact RANTES, has potent anti-HIV-1 activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Natural truncation of RANTES abolishes signaling through the CC chemokine receptors CCR1 and CCR3, impairs its chemotactic potency and generates a CC chemokine inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Citrullination of CXCL10 and CXCL11 by peptidylarginine deiminase: a naturally occurring posttranslational modification of chemokines and new dimension of immunoregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Citrullination of CXCL8 by peptidylarginine deiminase alters receptor usage, prevents proteolysis, and dampens tissue inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Structures of Human DPP7 Reveal the Molecular Basis of Specific Inhibition and the Architectural Diversity of Proline-Specific Peptidases

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Peptide substrates of dipeptidyl peptidases

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

A new dipeptide naphthylamidase hydrolyzing glycyl-prolyl-beta-naphthylamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Dipeptidyl-peptidase IV (CD26)--role in the inactivation of regulatory peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

CD26, let it cut or cut it down.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Dipeptidylpeptidase 4 negatively regulates colony-stimulating factor activity and stress hematopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

The role of dipeptidyl peptidase 4 in hematopoiesis and transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Implications of DPP4 modification of proteins that regulate stem/progenitor and more mature cell types

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Dipeptidyl peptidase IV substrates. An update on in vitro peptide hydrolysis by human DPPIV

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Increased rate of HIV-1 entry and its cytopathic effect in CD4 /CXCR4 T cells expressing relatively high levels of CD26.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

The structure and function of CD26 in the T‐cell immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Dipeptidyl‐peptidase IV/CD26 on T cells: analysis of an alternative T‐cell activation pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Proline-dependent structural and biological properties of peptides and proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

CD26/dipeptidyl peptidase IV in context. The different roles of a multifunctional ectoenzyme in malignant transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

The role of CD26/dipeptidyl peptidase IV in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

G-CSF- and GM-CSF-induced upregulation of CD26 peptidase downregulates the functional chemotactic response of CD34 CD38- human cord blood hematopoietic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Dipeptidyl-peptidase IV activity is correlated with colorectal cancer prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Increased plasma DPP4 activity is an independent predictor of the onset of metabolic syndrome in Chinese over 4 years: result from the China National Diabetes and Metabolic Disorders Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Shedding of dipeptidyl peptidase 4 is mediated by metalloproteases and up-regulated by hypoxia in human adipocytes and smooth muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

CD26 surface molecule involvement in T cell activation and lymphokine synthesis in rheumatoid and other inflammatory synovitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Chemokine Expression in Inflamed Adipose Tissue Is Mainly Mediated by NF-κB

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Coexpression and interaction of CXCL10 and CD26 in mesenchymal cells by synergising inflammatory cytokines: CXCL8 and CXCL10 are discriminative markers for autoimmune arthropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

DPP4 in cardiometabolic disease: recent insights from the laboratory and clinical trials of DPP4 inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Dipeptidyl peptidase-4 inhibitors in the treatment of type 2 diabetes: a comparative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Therapeutic approaches to preserve islet mass in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

DPP-4 inhibitors: impact on glycemic control and cardiovascular risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Long-term treatment with Sitagliptin, a dipeptidyl peptidase-4 inhibitor, reduces colon carcinogenesis and reactive oxygen species in 1,2-dimethylhydrazine-induced rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Stromal cell-derived factors 1alpha and 1beta, inflammatory protein-10 and interferon-inducible T cell chemo-attractant are novel substrates of dipeptidyl peptidase 8

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Processing of natural and recombinant CXCR3-targeting chemokines and implications for biological activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Proteolytic processing of CXCL11 by CD13/aminopeptidase N impairs CXCR3 and CXCR7 binding and signaling and reduces lymphocyte and endothelial cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Processing by CD26/dipeptidyl-peptidase IV reduces the chemotactic and anti-HIV-1 activity of stromal-cell-derived factor-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Anti-HIV-1 and chemotactic activities of human stromal cell-derived factor 1alpha (SDF-1alpha) and SDF-1beta are abolished by CD26/dipeptidyl peptidase IV-mediated cleavage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Negative regulation of the anti-human immunodeficiency virus and chemotactic activity of human stromal cell-derived factor 1alpha by CD26/dipeptidyl peptidase IV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Cell surface peptidase CD26/dipeptidylpeptidase IV regulates CXCL12/stromal cell-derived factor-1 alpha-mediated chemotaxis of human cord blood CD34 progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Diverging binding capacities of natural LD78beta isoforms of macrophage inflammatory protein-1alpha to the CC chemokine receptors 1, 3 and 5 affect their anti-HIV-1 activity and chemotactic potencies for neutrophils and eosinophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Natural truncation of the chemokine MIP-1 beta /CCL4 affects receptor specificity but not anti-HIV-1 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Amino-terminal processing of MIP-1beta/CCL4 by CD26/dipeptidyl-peptidase IV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Delayed production of biologically active O‐glycosylated forms of human eotaxin by tumor‐necrosis‐factor‐α‐stimulated dermal fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Significance of N-terminal proteolysis of CCL14a to activity on the chemokine receptors CCR1 and CCR5 and the human cytomegalovirus-encoded chemokine receptor US28.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

n-Nonanoyl-CC chemokine ligand 14, a potent CC chemokine ligand 14 analogue that prevents the recruitment of eosinophils in allergic airway inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Truncation of macrophage-derived chemokine by CD26/ dipeptidyl-peptidase IV beyond its predicted cleavage site affects chemotactic activity and CC chemokine receptor 4 interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Inhibition of HIV-1 Infection by the β-Chemokine MDC

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Kinetic investigation of chemokine truncation by CD26/dipeptidyl peptidase IV reveals a striking selectivity within the chemokine family

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Functional comparison of two human monocyte chemotactic protein-2 isoforms, role of the amino-terminal pyroglutamic acid and processing by CD26/dipeptidyl peptidase IV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Chemokine oligomerization and interactions with receptors and glycosaminoglycans: the role of structural dynamics in function

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Heparan sulfate/heparin oligosaccharides protect stromal cell-derived factor-1 (SDF-1)/CXCL12 against proteolysis induced by CD26/dipeptidyl peptidase IV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Signal transduction by CXC chemokine receptor 4. Stromal cell-derived factor 1 stimulates prolonged protein kinase B and extracellular signal-regulated kinase 2 activation in T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Chemokines in hematopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

The chemokine SDF-1 is a chemoattractant for human CD34 hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34 progenitors to peripheral blood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Differential processing of stromal-derived factor-1alpha and stromal-derived factor-1beta explains functional diversity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Natural proteolytic processing of hemofiltrate CC chemokine 1 generates a potent CC chemokine receptor (CCR)1 and CCR5 agonist with anti-HIV properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Urokinase plasminogen activator and plasmin efficiently convert hemofiltrate CC chemokine 1 into its active

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Immune regulation by atypical chemokine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Differential recognition and scavenging of native and truncated macrophage-derived chemokine (macrophage-derived chemokine/CC chemokine ligand 22) by the D6 decoy receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Recognition versus adaptive up-regulation and degradation of CC chemokines by the chemokine decoy receptor D6 are determined by their N-terminal sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8 T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Identification of a major co-receptor for primary isolates of HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Serum inactivation contributes to the failure of stromal-derived factor-1 to block HIV-I infection in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

In vivo processing of CXCL12α/SDF-1α after intravenous and subcutaneous administration to mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Quantification of intact and truncated stromal cell-derived factor-1α in circulation by immunoaffinity enrichment and tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Identification and characterization of circulating variants of CXCL12 from human plasma: effects on chemotaxis and mobilization of hematopoietic stem and progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

The LD78beta isoform of MIP-1alpha is the most potent CCR5 agonist and HIV-1-inhibiting chemokine

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

LD78beta, a non-allelic variant of human MIP-1alpha (LD78alpha), has enhanced receptor interactions and potent HIV suppressive activity

21 January 2018

2 references

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

21 January 2018

12 December 2020

The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Quantitative detection of therapeutic proteins and their metabolites in serum using antibody-coupled ProteinChip Arrays and SELDI-TOF-MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Circulating CD26 is negatively associated with inflammation in human and experimental arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Inhibition of CD26/dipeptidyl peptidase IV enhances CCL11/eotaxin-mediated recruitment of eosinophils in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

CXCL10 antagonism and plasma sDPPIV correlate with increasing liver disease in chronic HCV genotype 4 infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Truncated CXCL10 is associated with failure to achieve spontaneous clearance of acute hepatitis C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Discrimination of agonist and antagonist forms of CXCL10 in biological samples.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Skin homing of Sézary cells involves SDF-1-CXCR4 signaling and down-regulation of CD26/dipeptidylpeptidase IV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

The effect of CXCL12 processing on CD34 cell migration in myeloproliferative neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Glypican-3-mediated inhibition of CD26 by TFPI: a novel mechanism in hematopoietic stem cell homing and maintenance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

The Simpson-Golabi-Behmel syndrome causative glypican-3, binds to and inhibits the dipeptidyl peptidase activity of CD26

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

In vivo DPP-4 inhibition to enhance engraftment of single-unit cord blood transplants in adults with hematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Modelling the sitagliptin effect on dipeptidyl peptidase-4 activity in adults with haematological malignancies after umbilical cord blood haematopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1189/JLB.3MR0915-401R

Endothelial and leukocyte forms of IL-8. Conversion by thrombin and interactions with neutrophils.

21 January 2018

1 reference

12 December 2020

Identification of an N-terminally truncated form of the chemokine RANTES and granulocyte-macrophage colony-stimulating factor as major eosinophil attractants released by cytokine-stimulated dermal fibroblasts

1 reference

12 December 2020

International union of pharmacology. XXII. Nomenclature for chemokine receptors

1 reference

12 December 2020

CD26/dipeptidyl-peptidase IV down-regulates the eosinophil chemotactic potency, but not the anti-HIV activity of human eotaxin by affecting its interaction with CC chemokine receptor 3.

1 reference

12 December 2020

Cell surface peptidase CD26/DPPIV mediates G-CSF mobilization of mouse progenitor cells

1 reference

12 December 2020

Identification of a novel granulocyte chemotactic protein (GCP-2) from human tumor cells. In vitro and in vivo comparison with natural forms of GRO, IP-10, and IL-8.

1 reference

12 December 2020

CD26/dipeptidyl peptidase IV differentially regulates the chemotaxis of T cells and monocytes toward RANTES: possible mechanism for the switch from innate to acquired immune response

1 reference

12 December 2020

Enhanced anti-HIV-1 activity and altered chemotactic potency of NH2-terminally processed macrophage-derived chemokine (MDC) imply an additional MDC receptor

1 reference

12 December 2020

Increased expression of dipeptidyl peptidase IV in human mesothelial cells by malignant ascites from ovarian carcinoma patients

1 reference

12 December 2020

Posttranslational modifications affect the activity of the human monocyte chemotactic proteins MCP-1 and MCP-2: identification of MCP-2(6-76) as a natural chemokine inhibitor.

1 reference

12 December 2020

The neutrophil-activating proteins interleukin 8 and beta-thromboglobulin: in vitro and in vivo comparison of NH2-terminally processed forms

1 reference

12 December 2020

A comparative study of the neutrophil stimulatory activity in vitro and pro-inflammatory properties in vivo of 72 amino acid and 77 amino acid IL-8

1 reference

12 December 2020

Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4

1 reference

12 December 2020

Combinatorial content of CCL3L and CCL4L gene copy numbers influence HIV-AIDS susceptibility in Ukrainian children.

1 reference

12 December 2020

IL-4 induces eotaxin: a possible mechanism of selective eosinophil recruitment in helminth infection and atopy

1 reference

12 December 2020

Expression and functional role of dipeptidyl peptidase IV (CD26) on human natural killer cells

1 reference

12 December 2020

The role of chemokines in inflammatory joint disease

1 reference

12 December 2020

Dipeptidyl peptidase IV (CD 26) and aminopeptidase N (CD 13) catalyzed hydrolysis of cytokines and peptides with N-terminal cytokine sequences

1 reference

12 December 2020

CD26 expression in leprosy and other granulomatous diseases correlates with the production of interferon-gamma

1 reference

12 December 2020

Differential regulation of eosinophil chemokine signaling via CCR3 and non-CCR3 pathways

1 reference

12 December 2020

CD26/dipeptidyl peptidase IV and its role in cancer

1 reference

12 December 2020

Decreased expression of the memory marker CD26 on both CD4 and CD8 T lymphocytes of HIV-infected subjects.

1 reference

12 December 2020

Proline motifs in peptides and their biological processing

1 reference

12 December 2020

CD26 is essential for normal G-CSF–induced progenitor cell mobilization as determined by CD26−/− mice

1 reference

12 December 2020

Dipeptidyl peptidase IV (CD26) on T cells cleaves the CXC chemokine CXCL11 (I-TAC) and abolishes the stimulating but not the desensitizing potential of the chemokine.

1 reference

12 December 2020

Modulation of hematopoietic stem cell homing and engraftment by CD26

1 reference

12 December 2020

Sitagliptin as add-on therapy in insulin deficiency: biomarkers of therapeutic efficacy respond differently in type 1 and type 2 diabetes

1 reference

12 December 2020

Cleavage by CD26/dipeptidyl peptidase IV converts the chemokine LD78beta into a most efficient monocyte attractant and CCR1 agonist

1 reference

12 December 2020

Ta1, a novel 105 KD human T cell activation antigen defined by a monoclonal antibody

1 reference

12 December 2020

Identifiers

DOI

10.1189/JLB.3MR0915-401R

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26744452 AND SRC:MED&resulttype=core&format=json

10 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26744452 AND SRC:MED&resulttype=core&format=json

10 June 2020

26744452

1 reference